Suppr超能文献

抗高血压药物治疗的里程碑

Milestones in antihypertensive drug treatment.

作者信息

Tsoucalas Gregory, Karamanou Marianna, Vavuranakis Manolis, Sgantzos Markos, Stefanadis Christodoulos, Androutsos Georgios

机构信息

62-64 str. Kononos, Pagrati, 11633 Athens, Greece.

出版信息

Curr Pharm Des. 2015;21(6):705-8. doi: 10.2174/1381612820666141023163552.

Abstract

Hypertension provoked since the beginning of the 19th century a medical debate between physicians. The early antihypertensive agents were poorly tolerated. Progress towards more effective drugs, appeared after the 2nd World War. Thiocyanates, dehydrogenated alkaloids of ergot, barbiturates, bismuth and bromides, were soon replaced by phenoxbenzamine, hexamethonium, pentolinium, and mecamylamine. Thiazide diuretics were the biggest breakthrough during the early 1960's. Then Beta(β)-blockers and angiotensin-converting enzyme inhibitors heralded a new era, until 1995, when losartan, the first non-peptide anti-hypertensive drug, was introduced. The plethora of the antihypertensive drugs changed the relationship between physicians and patients, pushed medicine towards prevention, and altered the medical marketing forever.

摘要

自19世纪初以来,高血压引发了医生之间的医学争论。早期的抗高血压药物耐受性较差。第二次世界大战后出现了更有效药物的研发进展。硫氰酸盐、麦角脱氢生物碱、巴比妥类药物、铋和溴化物很快就被苯氧苄胺、六甲铵、喷托铵和美加明所取代。噻嗪类利尿剂是20世纪60年代初最大的突破。然后β受体阻滞剂和血管紧张素转换酶抑制剂开创了一个新时代,直到1995年,第一种非肽类抗高血压药物氯沙坦问世。大量的抗高血压药物改变了医生与患者之间的关系,推动医学走向预防,并永远改变了医疗营销。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验